ARALEZ PHARMACEUTICALS INC. Interest Paid, Excluding Capitalized Interest, Operating Activities
ARALEZ PHARMACEUTICALS INC. reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $6.77 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. interest paid, excluding capitalized interest, operating activities for the quarter ending 2018-03-31 was $6.77M, a 43.55% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. interest paid, excluding capitalized interest, operating activities for the quarter ending 2017-12-31 was $6.77M, a 1254.80% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. interest paid, excluding capitalized interest, operating activities for the quarter ending 2017-09-30 was $6.70M.
- ARALEZ PHARMACEUTICALS INC. interest paid, excluding capitalized interest, operating activities for the quarter ending 2017-06-30 was $6.63M.
- ARALEZ PHARMACEUTICALS INC. interest paid, excluding capitalized interest, operating activities for fiscal 2017 was $24.82M, a 1504.40% increase from fiscal 2016.
- ARALEZ PHARMACEUTICALS INC. interest paid, excluding capitalized interest, operating activities for fiscal 2016 was $1.55M.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 6 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|---|---|
| 2018-03-31 | $6.77M 10-Q · filed 2018-05-08 | $13.55M derived: sum of 2 quarters · filed 2018-05-08 | $20.25M derived: sum of 3 quarters · filed 2018-05-08 | $26.88M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $13.47M derived: sum of 2 quarters · filed 2018-03-14 | $20.10M derived: sum of 3 quarters · filed 2018-03-14 | $24.82M 10-K · filed 2018-03-14 |
| 2017-09-30 | $6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $13.33M derived: sum of 2 quarters · filed 2017-11-09 | $18.05M 10-Q · filed 2017-11-09 | $18.55M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $6.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $11.35M 10-Q · filed 2017-08-09 | $11.85M derived: sum of 3 quarters · filed 2018-05-08 | $11.35M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $4.72M 10-Q · filed 2018-05-08 | $5.22M derived: sum of 2 quarters · filed 2018-05-08 | $4.72M derived: sum of 3 quarters · filed 2018-05-08 | |
| 2016-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.00K derived: sum of 2 quarters · filed 2018-03-14 | $1.55M 10-K · filed 2018-03-14 | |
| 2016-09-30 | -$499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.05M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $1.55M 10-Q · filed 2017-08-09 |